IBDEI1FL ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25381,1,5,0)
 ;;=5^FAMILY HEALTH PROBL NEC
 ;;^UTILITY(U,$J,358.3,25381,2)
 ;;=^295549
 ;;^UTILITY(U,$J,358.3,25382,0)
 ;;=V61.05^^147^1590^12
 ;;^UTILITY(U,$J,358.3,25382,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25382,1,4,0)
 ;;=4^V61.05
 ;;^UTILITY(U,$J,358.3,25382,1,5,0)
 ;;=5^FAMLY DSRPT-CHLD CUSTODY
 ;;^UTILITY(U,$J,358.3,25382,2)
 ;;=^336803
 ;;^UTILITY(U,$J,358.3,25383,0)
 ;;=V61.03^^147^1590^13
 ;;^UTILITY(U,$J,358.3,25383,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25383,1,4,0)
 ;;=4^V61.03
 ;;^UTILITY(U,$J,358.3,25383,1,5,0)
 ;;=5^FMILY DSRPT- DIVORCE/SEP
 ;;^UTILITY(U,$J,358.3,25383,2)
 ;;=^336801
 ;;^UTILITY(U,$J,358.3,25384,0)
 ;;=V61.01^^147^1590^14
 ;;^UTILITY(U,$J,358.3,25384,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25384,1,4,0)
 ;;=4^V61.01
 ;;^UTILITY(U,$J,358.3,25384,1,5,0)
 ;;=5^FMILY DSRPT-FAM MILITARY
 ;;^UTILITY(U,$J,358.3,25384,2)
 ;;=^336799
 ;;^UTILITY(U,$J,358.3,25385,0)
 ;;=V61.02^^147^1590^15
 ;;^UTILITY(U,$J,358.3,25385,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25385,1,4,0)
 ;;=4^V61.02
 ;;^UTILITY(U,$J,358.3,25385,1,5,0)
 ;;=5^FMILY DSRPT-RET MILITARY
 ;;^UTILITY(U,$J,358.3,25385,2)
 ;;=^336800
 ;;^UTILITY(U,$J,358.3,25386,0)
 ;;=V61.29^^147^1590^16
 ;;^UTILITY(U,$J,358.3,25386,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25386,1,4,0)
 ;;=4^V61.29
 ;;^UTILITY(U,$J,358.3,25386,1,5,0)
 ;;=5^PARENT-CHILD PROBLEM NEC
 ;;^UTILITY(U,$J,358.3,25386,2)
 ;;=^87774
 ;;^UTILITY(U,$J,358.3,25387,0)
 ;;=V61.3^^147^1590^17
 ;;^UTILITY(U,$J,358.3,25387,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25387,1,4,0)
 ;;=4^V61.3
 ;;^UTILITY(U,$J,358.3,25387,1,5,0)
 ;;=5^PROBLEM W AGED PARENT
 ;;^UTILITY(U,$J,358.3,25387,2)
 ;;=^295547
 ;;^UTILITY(U,$J,358.3,25388,0)
 ;;=V61.8^^147^1590^10
 ;;^UTILITY(U,$J,358.3,25388,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25388,1,4,0)
 ;;=4^V61.8
 ;;^UTILITY(U,$J,358.3,25388,1,5,0)
 ;;=5^FAMILY HEALTH CIRCUMSTANCES NEC
 ;;^UTILITY(U,$J,358.3,25388,2)
 ;;=^88048
 ;;^UTILITY(U,$J,358.3,25389,0)
 ;;=V16.0^^147^1591^11
 ;;^UTILITY(U,$J,358.3,25389,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25389,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,25389,1,5,0)
 ;;=5^FAMILY HX-GI MALIGNANCY
 ;;^UTILITY(U,$J,358.3,25389,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,25390,0)
 ;;=V16.1^^147^1591^14
 ;;^UTILITY(U,$J,358.3,25390,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25390,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,25390,1,5,0)
 ;;=5^FM HX-TRACH/BRONCHOG MAL
 ;;^UTILITY(U,$J,358.3,25390,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,25391,0)
 ;;=V16.2^^147^1591^6
 ;;^UTILITY(U,$J,358.3,25391,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25391,1,4,0)
 ;;=4^V16.2
 ;;^UTILITY(U,$J,358.3,25391,1,5,0)
 ;;=5^FAM HX-INTRATHORACIC MAL
 ;;^UTILITY(U,$J,358.3,25391,2)
 ;;=^295294
 ;;^UTILITY(U,$J,358.3,25392,0)
 ;;=V16.3^^147^1591^10
 ;;^UTILITY(U,$J,358.3,25392,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25392,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,25392,1,5,0)
 ;;=5^FAMILY HX-BREAST MALIG
 ;;^UTILITY(U,$J,358.3,25392,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,25393,0)
 ;;=V16.40^^147^1591^1
 ;;^UTILITY(U,$J,358.3,25393,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25393,1,4,0)
 ;;=4^V16.40
 ;;^UTILITY(U,$J,358.3,25393,1,5,0)
 ;;=5^FAM HX MALIG NEOPL,GENITAL
 ;;^UTILITY(U,$J,358.3,25393,2)
 ;;=^295296
 ;;^UTILITY(U,$J,358.3,25394,0)
 ;;=V16.41^^147^1591^2
 ;;^UTILITY(U,$J,358.3,25394,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25394,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,25394,1,5,0)
 ;;=5^FAM HX, MALIG NEOPL OF OVARY
 ;;^UTILITY(U,$J,358.3,25394,2)
 ;;=^317951
 ;;
 ;;$END ROU IBDEI1FL
